Skip to main content

Table 2 Cancer excluded from secondary endpoint all cancer risk

From: Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

Men (cancers excluded) Women (cancers excluded)
Non-melanoma skin cancer Non-melanoma skin cancer
Breast Prostate
Ovarian Male genital organs
Female genital organs